Matches in Nanopublications for { ?s ?p "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 25 of
25
with 100 items per page.
- NP913718.RABi6fu9Fb_H1ntQPQUaPlcIRMoOhqYkmlSHy3_6UzSyY130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913718.RABi6fu9Fb_H1ntQPQUaPlcIRMoOhqYkmlSHy3_6UzSyY130_provenance.
- NP775071.RAsq1yHTAWg9rFtKlqWXgE27euNEegmoDVuczHYhO6pJI130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775071.RAsq1yHTAWg9rFtKlqWXgE27euNEegmoDVuczHYhO6pJI130_provenance.
- NP863883.RAsVqbYZ9g3b1tgc_I5aI1f-NmMD4ptNMFqw3ZkltO5fw130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863883.RAsVqbYZ9g3b1tgc_I5aI1f-NmMD4ptNMFqw3ZkltO5fw130_provenance.
- NP864715.RAtUXzTv-goq7WXo63aFVdwLDY7qnOzx3upyvb_LSyCl8130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864715.RAtUXzTv-goq7WXo63aFVdwLDY7qnOzx3upyvb_LSyCl8130_provenance.
- NP605014.RAvfoP5quZb63WQc428GsKvaF2cpb2nLIBoEGrYkQJe2c130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605014.RAvfoP5quZb63WQc428GsKvaF2cpb2nLIBoEGrYkQJe2c130_provenance.
- NP826886.RAv3l3E5wX4lFv2ndU8T3QPJ00IZT2DBV08iw9gs2dlfE130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826886.RAv3l3E5wX4lFv2ndU8T3QPJ00IZT2DBV08iw9gs2dlfE130_provenance.
- NP270352.RA8BAFSwBwWgyTC9BK4Qqv62PnyK-gzzFELgDeGJKML5E130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270352.RA8BAFSwBwWgyTC9BK4Qqv62PnyK-gzzFELgDeGJKML5E130_provenance.
- assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP913655.RAYSlnQkhslk4j7xNec01xrsaaKIvZRJNCOsRYYtamyaI130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913655.RAYSlnQkhslk4j7xNec01xrsaaKIvZRJNCOsRYYtamyaI130_provenance.
- NP534814.RARW620MWKZVL6tKzotSGAxEUWKu9TzNrNaTphORxj1Ak130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534814.RARW620MWKZVL6tKzotSGAxEUWKu9TzNrNaTphORxj1Ak130_provenance.
- assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP315098.RAq3tTkGfo-9uVFWn_gTndrZC210Sxrkk6zki-qD2LN80130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315098.RAq3tTkGfo-9uVFWn_gTndrZC210Sxrkk6zki-qD2LN80130_provenance.
- NP926524.RAbo1HaqOnUhxcnS56vXRi74pgWKWMzKysKZxoIJxvwI0130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926524.RAbo1HaqOnUhxcnS56vXRi74pgWKWMzKysKZxoIJxvwI0130_provenance.
- NP926522.RAt85bvMBExdZO-hpGg2HSmInMhq1dEgCFnoLlevdpLYY130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926522.RAt85bvMBExdZO-hpGg2HSmInMhq1dEgCFnoLlevdpLYY130_provenance.
- NP926523.RAvDVi1hQA4eEDQ_h8Scp3gJ4rRNbTlli7uYQWkcr85LU130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926523.RAvDVi1hQA4eEDQ_h8Scp3gJ4rRNbTlli7uYQWkcr85LU130_provenance.
- NP926525.RAvIqr38QTlQpsog_LM68MYuFa8IOh7MbSErmpB_iUVnU130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926525.RAvIqr38QTlQpsog_LM68MYuFa8IOh7MbSErmpB_iUVnU130_provenance.
- NP315076.RAw4oDbf8dGBC4_EDDStg0z5w_sv33UMUSHR-0VVIkLOk130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315076.RAw4oDbf8dGBC4_EDDStg0z5w_sv33UMUSHR-0VVIkLOk130_provenance.
- NP535009.RA8Ed3wuHIEdTFIUWAXJv4eecm2nD2uEKxU7Av119P9zQ130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535009.RA8Ed3wuHIEdTFIUWAXJv4eecm2nD2uEKxU7Av119P9zQ130_provenance.
- NP535017.RA1156IKly9ktyQQxEq3nxJ1rxuFGkR3xpUWliqZspV08130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535017.RA1156IKly9ktyQQxEq3nxJ1rxuFGkR3xpUWliqZspV08130_provenance.
- NP913700.RA0zqMl2VunHya6THwEXxkWaNZiOFi6WdpPLt3TQODa1Q130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913700.RA0zqMl2VunHya6THwEXxkWaNZiOFi6WdpPLt3TQODa1Q130_provenance.
- NP913702.RA3N7-Fp6WezzWu0kasfwO919qWd-JelbSco1qHhtayyc130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913702.RA3N7-Fp6WezzWu0kasfwO919qWd-JelbSco1qHhtayyc130_provenance.
- NP926520.RA_6pdfls2V-IlNzZKNMRe_G9QxH5znlAfeur6LEN3ZPM130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926520.RA_6pdfls2V-IlNzZKNMRe_G9QxH5znlAfeur6LEN3ZPM130_provenance.
- NP926521.RA2au0gHL4HKyRCUnlQm8wsnocP_gnZxEJkfk2V0C70XA130_assertion description "[DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926521.RA2au0gHL4HKyRCUnlQm8wsnocP_gnZxEJkfk2V0C70XA130_provenance.